EMERGENT BIOSOLUT Financials
| ER4 Stock | EUR 5.25 0.08 1.50% |
EMERGENT |
Understanding current and past EMERGENT BIOSOLUT Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of EMERGENT BIOSOLUT's financial statements are interrelated, with each one affecting the others. For example, an increase in EMERGENT BIOSOLUT's assets may result in an increase in income on the income statement.
Please note, the presentation of EMERGENT BIOSOLUT's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, EMERGENT BIOSOLUT's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of EMERGENT BIOSOLUT's management manipulating its earnings.
You should never invest in EMERGENT BIOSOLUT without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of EMERGENT Stock, because this is throwing your money away. Analyzing the key information contained in EMERGENT BIOSOLUT's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
EMERGENT BIOSOLUT Key Financial Ratios
There are many critical financial ratios that EMERGENT BIOSOLUT's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that EMERGENT BIOSOLUT reports annually and quarterly.EMERGENT Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EMERGENT BIOSOLUT's current stock value. Our valuation model uses many indicators to compare EMERGENT BIOSOLUT value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EMERGENT BIOSOLUT competition to find correlations between indicators driving EMERGENT BIOSOLUT's intrinsic value. More Info.EMERGENT BIOSOLUT is rated # 3 in current valuation category among its peers. It also is rated # 3 in price to book category among its peers . The ratio of Current Valuation to Price To Book for EMERGENT BIOSOLUT is about 3,145,353,769 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EMERGENT BIOSOLUT's earnings, one of the primary drivers of an investment's value.EMERGENT BIOSOLUT Systematic Risk
EMERGENT BIOSOLUT's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. EMERGENT BIOSOLUT volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was five with a total number of output elements of fifty-six. The Beta measures systematic risk based on how returns on EMERGENT BIOSOLUT correlated with the market. If Beta is less than 0 EMERGENT BIOSOLUT generally moves in the opposite direction as compared to the market. If EMERGENT BIOSOLUT Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one EMERGENT BIOSOLUT is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of EMERGENT BIOSOLUT is generally in the same direction as the market. If Beta > 1 EMERGENT BIOSOLUT moves generally in the same direction as, but more than the movement of the benchmark.
EMERGENT BIOSOLUT March 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of EMERGENT BIOSOLUT help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of EMERGENT BIOSOLUT. We use our internally-developed statistical techniques to arrive at the intrinsic value of EMERGENT BIOSOLUT based on widely used predictive technical indicators. In general, we focus on analyzing EMERGENT Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build EMERGENT BIOSOLUT's daily price indicators and compare them against related drivers.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 35.27 | |||
| Value At Risk | (7.12) | |||
| Potential Upside | 6.27 |
Complementary Tools for EMERGENT Stock analysis
When running EMERGENT BIOSOLUT's price analysis, check to measure EMERGENT BIOSOLUT's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMERGENT BIOSOLUT is operating at the current time. Most of EMERGENT BIOSOLUT's value examination focuses on studying past and present price action to predict the probability of EMERGENT BIOSOLUT's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMERGENT BIOSOLUT's price. Additionally, you may evaluate how the addition of EMERGENT BIOSOLUT to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |